Counterfeit Lipitor Settlement

The generic drug maker Ranbaxy pleaded guilty on Monday to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold subpar drugs and made false statements to the¬†Food and Drug Administration¬†about its manufacturing practices at two factories in India, the company and federal prosecutors announced Monday. The settlement […]